II

Dr. Phillips is a national leader in the treatment of hematologic malignancies and is an innovator in bringing transplant modalities to lymphoma. He is a graduate of the University of Oklahoma School of Medicine where he completed his internship in internal medicine. He continued his residency training at the University of North Carlina School of Medicine and trained at Washington University School of Medicine with a clinical and research fellowship in hematology/oncology. He previously directed the transplant programs at the University of Maryland, University of Kentucky, theUniversity of British Columbia, and Barnes Hospital at the Washington University School of Medicine. Dr. Phillips was the principal investigator of the National Cancer Institute (NCI) study "Improving the Ability of (High-Risk) Hematologic Malignancy Patients to Undergo Allogenic Stem Cell Transplantation". Dr. Phillips is a member of several editorial boards and has authored and/or co-authored over 200 publications. His research interests include nonmyeloablative (min-dose) transplants and 'alternative donors' for allogenic transplants. He has developed several innovative clinical trials related to stem cell transplantation and is particularly interested in lymphoma, leukemia, and multiple myeloma.

• Phillips GL. Allogeneic hematopoietic stem cell transplantation (HSCT) for high-risk acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS): How can we improve outcomes in the near future? Leuk Res. 2012 Dec; 36(12):1490-5.
  View in: PubMed
• Blumberg N, Heal JM, Phillips GL, Phipps RP. Platelets--to transfuse or not to transfuse. Lancet. 2012 Oct 13; 380(9850):1287-9.
  View in: PubMed
• Reid R, Bennett JM, Becker M, Chen Y, Milner L, Phillips Ii GL, Liesveld J. Use of eltrombopag, a thrombopoietin receptor agonist, in post-transplantation thrombocytopenia. Am J Hematol. 2012 Jul; 87(7):743-5.
  View in: PubMed
• Biswas T, Culakova E, Friedberg JW, Kelly JL, Dhakal S, Liesveld J, Phillips GL, Constine LS. Involved field radiation therapy following high dose chemotherapy and autologous stem cell transplant benefits local control and survival in refractory or recurrent Hodgkin lymphoma. Radiother Oncol. 2012 Jun; 103(3):367-72.
  View in: PubMed
• Ban-Hoefen M, Kelly JL, Bernstein SH, Liesveld J, Constine L, Becker M, Milner L, Phillips G, Friedberg JW. High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era. Leuk Lymphoma. 2012 May; 53(5):830-5.
  View in: PubMed
• Keller SF, Kelly JL, Sensenig E, Andreozzi J, Oliva J, Rich L, Constine L, Becker M, Phillips G, Liesveld J, Fisher RI, Bernstein SH, Friedberg JW. Late Relapses following High-Dose Autologous Stem Cell Transplantation (HD-ASCT) for Hodgkin's Lymphoma (HL) in the ABVD Therapeutic Era. Biol Blood Marrow Transplant. 2012 Apr; 18(4):640-7.
  View in: PubMed
• Milner LA, Becker MW, Bernstein SH, Bruckner L, Friedberg JW, Holland GA, Ifthikharuddin JJ, Liesveld JL, Mathes EJ, Menchel HL, Mullen CA, Sasson T, Phillips GL. Intra-arterial methylprednisolone for the management of steroid-refractory acute gastrointestinal and hepatic graft versus host disease. Am J Hematol. 2011 Aug; 86(8):712-4.
  View in: PubMed
• Phillips GL, Bernstein SH, Liesveld JL, Abboud CN, Becker MW, Constine LS, Ifthikharuddin JJ, Loughner JE, Milner LA, Vesole DH, Friedberg JW. A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotection. Biol Blood Marrow Transplant. 2011 Jul; 17(7):1033-42.
  View in: PubMed
• Blumberg N, Heal JM, Phillips GL. Platelet transfusions: trigger, dose, benefits, and risks. F1000 Med Rep. 2010; 2:5.
  View in: PubMed
• Hasserjian RP, Zuo Z, Garcia C, Tang G, Kasyan A, Luthra R, Abruzzo LV, Kantarjian HM, Medeiros LJ, Wang SA. Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification. Blood. 2010 Mar 11; 115(10):1985-92.
  View in: PubMed
• Litzow MR, Tarima S, Pérez WS, Bolwell BJ, Cairo MS, Camitta BM, Cutler CS, de Lima M, Dipersio JF, Gale RP, Keating A, Lazarus HM, Luger S, Marks DI, Maziarz RT, McCarthy PL, Pasquini MC, Phillips GL, Rizzo JD, Sierra J, Tallman MS, Weisdorf DJ. Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood. 2010 Mar 4; 115(9):1850-7.
  View in: PubMed
• Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE, McLaughlin S, Phillips GL, Robertson RP, Rubino F, Kahn R, Kirkman MS. How do we define cure of diabetes? Diabetes Care. 2009 Nov; 32(11):2133-5.
  View in: PubMed
• Biswas T, Dhakal S, Chen R, Hyrien O, Bernstein S, Friedberg JW, Fisher RI, Liesveld J, Phillips G, Constine LS. Involved field radiation after autologous stem cell transplant for diffuse large B-cell lymphoma in the rituximab era. Int J Radiat Oncol Biol Phys. 2010 May 1; 77(1):79-85.
  View in: PubMed
• Dhakal S, Biswas T, Liesveld JL, Friedberg JW, Phillips GL, Constine LS. Patterns and timing of initial relapse in patients subsequently undergoing transplantation for Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 2009 Sep 1; 75(1):188-92.
  View in: PubMed
• Bierman PJ, Phillips GL. Role of hematopoietic stem cell transplantation in the treatment of non-Hodgkin's lymphoma. Cancer Treat Res. 2009; 144:357-97.
  View in: PubMed
• Walker AR, Komrokji RS, Ifthikharuddin J, Messina P, Mulford D, Becker M, Friedberg J, Oliva J, Phillips G, Liesveld JL, Abboud C. Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML. Leuk Res. 2008 Dec; 32(12):1830-6.
  View in: PubMed
• Lazarus HM, Phillips GL, Herzig RH, Hurd DD, Wolff SN, Herzig GP. High-dose melphalan and the development of hematopoietic stem-cell transplantation: 25 years later. J Clin Oncol. 2008 May 10; 26(14):2240-3.
  View in: PubMed
• Blumberg N, Heal JM, Liesveld JL, Phillips GL, Rowe JM. Platelet transfusion and survival in adults with acute leukemia. Leukemia. 2008 Mar; 22(3):631-5.
  View in: PubMed
• Liesveld JL, Bechelli J, Rosell K, Lu C, Bridger G, Phillips G, Abboud CN. Effects of AMD3100 on transmigration and survival of acute myelogenous leukemia cells. Leuk Res. 2007 Nov; 31(11):1553-63.
  View in: PubMed
• Tallman MS, Pérez WS, Lazarus HM, Gale RP, Maziarz RT, Rowe JM, Marks DI, Cahn JY, Bashey A, Bishop MR, Christiansen N, Frankel SR, García JJ, Ilhan O, Laughlin MJ, Liesveld J, Linker C, Litzow MR, Luger S, McCarthy PL, Milone GA, Pavlovsky S, Phillips GL, Russell JA, Saez RA, Schiller G, Sierra J, Weiner RS, Zander AR, Zhang MJ, Keating A, Weisdorf DJ, Horowitz MM. Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission. Biol Blood Marrow Transplant. 2006 Feb; 12(2):204-16.
  View in: PubMed
• Liesveld JL, Rosell KE, Lu C, Bechelli J, Phillips G, Lancet JE, Abboud CN. Acute myelogenous leukemia--microenvironment interactions: role of endothelial cells and proteasome inhibition. Hematology. 2005 Dec; 10(6):483-94.
  View in: PubMed
• Heal JM, Liesveld JL, Phillips GL, Blumberg N. What would Karl Landsteiner do? The ABO blood group and stem cell transplantation. Bone Marrow Transplant. 2005 Nov; 36(9):747-55.
  View in: PubMed
• Lavoie JC, Connors JM, Phillips GL, Reece DE, Barnett MJ, Forrest DL, Gascoyne RD, Hogge DE, Nantel SH, Shepherd JD, Smith CA, Song KW, Sutherland HJ, Toze CL, Voss NJ, Nevill TJ. High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver. Blood. 2005 Aug 15; 106(4):1473-8.
  View in: PubMed
• Phillips GL, Abboud CN, Bernstein SH, Friedberg JW, Ifthikharuddin JJ, Lancet JE, Liesveld JL, Spreng E, Johnson V, Chapman M, Vesole DH. Phase I study for poor-prognosis lymphoma: augmentation of the "BEAM" regimen with escalating dose melphalan using amifostine cytoprotection and autologous hematopoietic stem cell transplantation--a preliminary report. Semin Oncol. 2004 Dec; 31(6 Suppl 18):59-61.
  View in: PubMed
• Thompson JS, Pomeroy C, Kryscio RJ, Brown SA, Reece D, Kramer R, Howard DS, VanZant G, Humphries S, Phillips G. Use of a T cell-specific monoclonal antibody, T10B9, in a novel allogeneic stem cell transplantation protocol for hematologic malignancy high-risk patients. Biol Blood Marrow Transplant. 2004 Dec; 10(12):858-66.
  View in: PubMed
• Rapoport AP, Guo C, Badros A, Hakimian R, Akpek G, Kiggundu E, Meisenberg B, Mannuel H, Takebe N, Fenton R, Bolaños-Meade J, Heyman M, Gojo I, Ruehle K, Natt S, Ratterree B, Withers T, Sarkodee-Adoo C, Phillips GL, Tricot G. Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphoma. Bone Marrow Transplant. 2004 Nov; 34(10):883-90.
  View in: PubMed
• Phillips GL, Meisenberg B, Reece DE, Adams VR, Badros A, Brunner J, Fenton R, Filicko J, Grosso D, Hale GA, Howard DS, Johnson VP, Kniska A, Marshall KW, Nath R, Reed E, Rapoport AP, Takebe N, Vesole DH, Wagner JL, Flomenberg N. Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I study. Biol Blood Marrow Transplant. 2004 Jul; 10(7):473-83.
  View in: PubMed
• Phillips GL, Meisenberg BR, Reece DE, Adams VR, Badros AZ, Brunner JL, Fenton RG, Filicko J, Grosso DL, Hale GA, Howard DS, Johnson VP, Kniska A, Marshall KW, Mookerjee B, Nath R, Rapoport AP, Sarkodee-Adoo C, Takebe N, Vesole DH, Wagner JL, Flomenberg N. Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma. Bone Marrow Transplant. 2004 Apr; 33(8):781-7.
  View in: PubMed
• Liesveld JL, Jordan CT, Phillips GL. The hematopoietic stem cell in myelodysplasia. Stem Cells. 2004; 22(4):590-9.
  View in: PubMed
• Horan JT, Liesveld JL, Fernandez ID, Lyman GH, Phillips GL, Lerner NB, Fisher SG. Survival after HLA-identical allogeneic peripheral blood stem cell and bone marrow transplantation for hematologic malignancies: meta-analysis of randomized controlled trials. Bone Marrow Transplant. 2003 Aug; 32(3):293-8.
  View in: PubMed
• Bolaños-Meade J, Phillips GL, Badros A. Tandem transplantation in multiple myeloma. Oncology (Williston Park). 2003 Mar; 17(3):389-98; discussion 398-400, 405-7.
  View in: PubMed
• Reece DE, Foon KA, Bhattarcharya-Chatterjee M, Adkins D, Broun ER, Connaghan DG, Dipersio JF, Holland HK, Howard DA, Hale GA, Klingemann HG, Munn RK, Raptis A, Phillips GL. Use of the anti-idiotype breast cancer vaccine 11D10 in conjunction with autologous stem cell transplantation in patients with metastatic breast cancer. Clin Breast Cancer. 2003 Feb; 3 Suppl 4:S152-7.
  View in: PubMed
• Phillips GL. The potential of amifostine in high-dose chemotherapy and autologous hematopoietic stem cell transplantation. Semin Oncol. 2002 Dec; 29(6 Suppl 19):53-6.
  View in: PubMed
• Rapoport AP, Meisenberg B, Sarkodee-Adoo C, Fassas A, Frankel SR, Mookerjee B, Takebe N, Fenton R, Heyman M, Badros A, Kennedy A, Jacobs M, Hudes R, Ruehle K, Smith R, Kight L, Chambers S, MacFadden M, Cottler-Fox M, Chen T, Phillips G, Tricot G. Autotransplantation for advanced lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapy. Bone Marrow Transplant. 2002 Feb; 29(4):303-12.
  View in: PubMed
• Guzman ML, Upchurch D, Grimes B, Howard DS, Rizzieri DA, Luger SM, Phillips GL, Jordan CT. Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells. Blood. 2001 Apr 1; 97(7):2177-9.
  View in: PubMed
• Reece DE, Foon KA, Battacharya-Chatterjee M, Adkins D, Broun ER, Connaghan DG, Dipersio JF, Holland HK, Howard DS, Hale GA, Klingemann HG, Munn RK, Raptis A, Phillips GL. Interim analysis of the use of the anti-idiotype breast cancer vaccine 11D10 (TriAb) in conjunction with autologous stem cell transplantation in patients with metastatic breast cancer. Clin Breast Cancer. 2001 Apr; 2(1):52-8.
  View in: PubMed
• Hale GA, Phillips GL. Allogeneic stem cell transplantation for the non-Hodgkin's lymphomas and Hodgkin's disease. Cancer Treat Rev. 2000 Dec; 26(6):411-27.
  View in: PubMed
• Jordan CT, Upchurch D, Szilvassy SJ, Guzman ML, Howard DS, Pettigrew AL, Meyerrose T, Rossi R, Grimes B, Rizzieri DA, Luger SM, Phillips GL. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia. 2000 Oct; 14(10):1777-84.
  View in: PubMed
• Reece DE, Foon KA, Bhattacharya-Chatterjee M, Hale GA, Howard DS, Munn RK, Nath R, Plummer BA, Teitelbaum A, Phillips GL. Use of the anti-idiotype antibody vaccine TriAb after autologous stem cell transplantation in patients with metastatic breast cancer. Bone Marrow Transplant. 2000 Oct; 26(7):729-35.
  View in: PubMed
• Reece DE, Brockington DA, Phillips GL, Barnett MJ, Klingemann HG, Nantel SH, Sutherland HJ, Shepherd JD. Prolonged survival after intensive therapy and purged ABMT in patients with multiple myeloma. Bone Marrow Transplant. 2000 Sep; 26(6):621-6.
  View in: PubMed
• Toze CL, Shepherd JD, Connors JM, Voss NJ, Gascoyne RD, Hogge DE, Klingemann HG, Nantel SH, Nevill TJ, Phillips GL, Reece DE, Sutherland HJ, Barnett MJ. Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia. Bone Marrow Transplant. 2000 Mar; 25(6):605-12.
  View in: PubMed
• Hale GA, Reece DE, Munn RK, Kniska AB, Phillips GL. Blood tacrolimus concentrations in bone marrow transplant patients undergoing plasmapheresis. Bone Marrow Transplant. 2000 Feb; 25(4):449-51.
  View in: PubMed
• Toze CL, Shepherd JD, Connors JM, Voss NJ, Gascoyne RD, Hogge DE, Klingemann HG, Nantel SH, Nevill TJ, Phillips GL, Reece DE, Sutherland HJ, Conneally EA, Barnett MJ. Allografting for indolent lymphoid neoplasms. Ann Oncol. 2000; 11 Suppl 1:59-61.
  View in: PubMed
• Andrykowski MA, Cordova MJ, Hann DM, Jacobsen PB, Fields KK, Phillips G. Patients' psychosocial concerns following stem cell transplantation. Bone Marrow Transplant. 1999 Nov; 24(10):1121-9.
  View in: PubMed
• Howard DS, Rizzierri DA, Grimes B, Upchurch D, Phillips GL, Stewart AK, Yannelli JR, Jordan CT. Genetic manipulation of primitive leukemic and normal hematopoietic cells using a novel method of adenovirus-mediated gene transfer. Leukemia. 1999 Oct; 13(10):1608-16.
  View in: PubMed
• Phillips GL, Davey DD, Hale GA, Marshall KW, Munn RK, Nath R, Reece DE, Van Zant G. Granulocyte-colony stimulating factor (G-CSF)-primed, delayed marrow harvests as a source of hematopoietic stem and progenitor cells for allogeneic transplantation. Leuk Lymphoma. 1999 Oct; 35(3-4):303-9.
  View in: PubMed
• Reece DE, Nevill TJ, Sayegh A, Spinelli JJ, Brockington DA, Barnett MJ, Klingemann HG, Connors JM, Nantel SH, Shepherd JD, Sutherland HJ, Voss NJ, Fairey RN, O'Reilly SE, Phillips GL. Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin's disease. Bone Marrow Transplant. 1999 Jun; 23(11):1131-8.
  View in: PubMed
• Lazarus HM, Rowlings PA, Zhang MJ, Vose JM, Armitage JO, Bierman PJ, Gajewski JL, Gale RP, Keating A, Klein JP, Miller CB, Phillips GL, Reece DE, Sobocinski KA, van Besien K, Horowitz MM. Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol. 1999 Feb; 17(2):534-45.
  View in: PubMed
• Przepiorka D, Phillips GL, Ratanatharathorn V, Cottler-Fox M, Sehn LH, Antin JH, LeBherz D, Awwad M, Hope J, McClain JB. A phase II study of BTI-322, a monoclonal anti-CD2 antibody, for treatment of steroid-resistant acute graft-versus-host disease. Blood. 1998 Dec 1; 92(11):4066-71.
  View in: PubMed
• Gale RP, Park RE, Dubois R, Bierman PJ, Fisher RI, Loh KK, Peterson BA, Phillips GL, Portlock CS, Rosenblum D, Armitage JO. Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in diffuse large-cell lymphoma. Leuk Lymphoma. 1998 Dec; 32(1-2):139-49.
  View in: PubMed
• van Besien K, Sobocinski KA, Rowlings PA, Murphy SC, Armitage JO, Bishop MR, Chaekal OK, Gale RP, Klein JP, Lazarus HM, McCarthy PL, Raemaekers JM, Reiffers J, Phillips GL, Schattenberg AV, Verdonck LF, Vose JM, Horowitz MM. Allogeneic bone marrow transplantation for low-grade lymphoma. Blood. 1998 Sep 1; 92(5):1832-6.
  View in: PubMed
• Jackson SR, Tweeddale MG, Barnett MJ, Spinelli JJ, Sutherland HJ, Reece DE, Klingemann HG, Nantel SH, Fung HC, Toze CL, Phillips GL, Shepherd JD. Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors. Bone Marrow Transplant. 1998 Apr; 21(7):697-704.
  View in: PubMed
• Koç ON, Gerson SL, Phillips GL, Cooper BW, Kutteh L, Van Zant G, Reece DE, Fox RM, Schupp JE, Tainer N, Lazarus HM. Autologous CD34+ cell transplantation for patients with advanced lymphoma: effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment. Bone Marrow Transplant. 1998 Feb; 21(4):337-43.
  View in: PubMed
• Bernstein SH, Eaves CJ, Herzig R, Fay J, Lynch J, Phillips GL, Christiansen N, Reece D, Ericson S, Stephan M, Kovalsky M, Hawkins K, Rasmussen H, Devos A, Herzig GP. A randomized phase II study of BB-10010: a variant of human macrophage inflammatory protein-1alpha for patients receiving high-dose etoposide and cyclophosphamide for malignant lymphoma and breast cancer. Br J Haematol. 1997 Dec; 99(4):888-95.
  View in: PubMed
• Phillips GL, Reece DE, Wolff SN, Goldie JH. The use of conventional salvage chemotherapy before dose-intensive cytotoxic therapy and autologous transplantation for aggressive-histology lymphoma: a case for re-evaluation. Leuk Lymphoma. 1997 Aug; 26(5-6):507-13.
  View in: PubMed
• Dalal BI, Wu V, Barnett MJ, Horsman DE, Spinelli JJ, Naiman SC, Shepherd JD, Nantel SH, Reece DE, Sutherland HJ, Klingemann HG, Phillips GL. Induction failure in de novo acute myelogenous leukemia is associated with expression of high levels of CD34 antigen by the leukemic blasts. Leuk Lymphoma. 1997 Jul; 26(3-4):299-306.
  View in: PubMed
• Munn RK, Henslee-Downey PJ, Romond EH, Marciniak EJ, Fleming DR, Messino MJ, Macdonald JS, Rayens MK, Harder EJ, Phillips GL, Thompson JS. Treatment of leukemia with partially matched related bone marrow transplantation. Bone Marrow Transplant. 1997 Mar; 19(5):421-7.
  View in: PubMed
• Lower FE, Jennings CD, Phillips GL, Thompson JS. Utility of DRB1 subtyping: a case report. Clin Transplant. 1996 Dec; 10(6 Pt 2):598-600.
  View in: PubMed
• Reece DE, Phillips GL. Intensive therapy and autologous stem cell transplantation for Hodgkin's disease in first relapse after combination chemotherapy. Leuk Lymphoma. 1996 Apr; 21(3-4):245-53.
  View in: PubMed
• Shepherd JD, Hoar DI, Keown PA, Phillips GL. Successful paternity of twins following bone marrow transplantation with busulfan, melphalan and cyclophosphamide conditioning. Bone Marrow Transplant. 1996 Mar; 17(3):461-2.
  View in: PubMed
• Gajewski JL, Phillips GL, Sobocinski KA, Armitage JO, Gale RP, Champlin RE, Herzig RH, Hurd DD, Jagannath S, Klein JP, Lazarus HM, McCarthy PL, Pavlovsky S, Peterson FB, Rowlings PA, Russell JA, Silver SM, Vose JM, Wiernik PH, Bortin MM, Horowitz MM. Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease. J Clin Oncol. 1996 Feb; 14(2):572-8.
  View in: PubMed
• Dalal BI, Stockford GR, Naiman SC, Spinelli JJ, Phillips GL. Criteria for marrow engraftment: comparison of reticulocyte maturity index with conventional parameters. Bone Marrow Transplant. 1996 Jan; 17(1):91-2.
  View in: PubMed
• Kingreen D, Dalal BI, Heyman M, Phillips GL, Horsman D, Kidd P, Loughran TP. Lymphocytosis of large granular lymphocytes in patients with Hodgkin's disease. Am J Hematol. 1995 Dec; 50(4):234-6.
  View in: PubMed
• Phillips G, Armitage J, Bearman S, Bitran J, Fay J, Forman S, Hurd D, Lazarus H, Warkentin P, Wolf J, et al. American Society for Blood and Marrow Transplantation guidelines for clinical centers. Biol Blood Marrow Transplant. 1995 Nov; 1(1):54-5.
  View in: PubMed
• Fung H, Shepherd JD, Naiman SC, Barnett MJ, Reece DE, Horsman DE, Nantel SH, Sutherland HJ, Spinelli JJ, Klingemann HG, et al. Acute monocytic leukemia: a single institution experience. Leuk Lymphoma. 1995 Oct; 19(3-4):259-65.
  View in: PubMed
• Reece DE, Barnett MJ, Shepherd JD, Hogge DE, Klasa RJ, Nantel SH, Sutherland HJ, Klingemann HG, Fairey RN, Voss NJ, et al. High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy. Blood. 1995 Jul 15; 86(2):451-6.
  View in: PubMed
• Jackson SR, Barnett MJ, Keller O, Nantel SH, Phillips GL. Recovery from rhabdomyolysis after allogeneic BMT: report of a case with speculation on causation. Bone Marrow Transplant. 1995 May; 15(5):803-4.
  View in: PubMed
• Cuthbert RJ, Shepherd JD, Nantel SH, Barnett MJ, Reece DE, Klingemann HG, Chan KW, Spinelli JJ, Sutherland HJ, Phillips GL. Allogeneic bone marrow transplantation for severe aplastic anemia: the Vancouver experience. Clin Invest Med. 1995 Apr; 18(2):122-30.
  View in: PubMed
• Shepherd JD, Gascoyne RD, Barnett MJ, Coghlan JD, Phillips GL. Polyclonal Epstein-Barr virus-associated lymphoproliferative disorder following autografting for chronic myeloid leukemia. Bone Marrow Transplant. 1995 Apr; 15(4):639-41.
  View in: PubMed
• Phillips GL, Nevill TJ, Spinelli JJ, Nantel SH, Klingemann HG, Barnett MJ, Shepherd JD, Chan KW, Meharchand JM, Sutherland HJ, et al. Prophylaxis for acute graft-versus-host disease following unrelated donor bone marrow transplantation. Bone Marrow Transplant. 1995 Feb; 15(2):213-9.
  View in: PubMed
• Sutherland HJ, Hogge DE, Lansdorp PM, Phillips GL, Eaves AC, Eaves CJ. Quantitation, mobilization, and clinical use of long-term culture-initiating cells in blood cell autografts. J Hematother. 1995 Feb; 4(1):3-10.
  View in: PubMed
• Tezcan H, Barnett MJ, Bredeson CN, Reece DE, Shepherd JD, Dalal BI, Horsman DE, Klingemann HG, Nantel SH, Spinelli JJ, et al. Treatment of acute promyelocytic leukemia in patients presenting at Vancouver General Hospital from 1983 to 1992. Leuk Lymphoma. 1995 Feb; 16(5-6):439-44.
  View in: PubMed
• Klingemann HG, Phillips GL. Is there a place for immunotherapy with interleukin-2 to prevent relapse after autologous stem cell transplantation for acute leukemia? Leuk Lymphoma. 1995 Feb; 16(5-6):397-405.
  View in: PubMed
• Phillips G. Prognostic factors in Hodgkin's disease: problems and pitfalls. Leuk Lymphoma. 1995; 15 Suppl 1:43-5.
  View in: PubMed
• Reece DE, Shepherd JD, Klingemann HG, Sutherland HJ, Nantel SH, Barnett MJ, Spinelli JJ, Phillips GL. Treatment of myeloma using intensive therapy and allogeneic bone marrow transplantation. Bone Marrow Transplant. 1995 Jan; 15(1):117-23.
  View in: PubMed
• Schultz KR, Green GJ, Wensley D, Sargent MA, Magee JF, Spinelli JJ, Pritchard S, Davis JH, Rogers PC, Chan KW, et al. Obstructive lung disease in children after allogeneic bone marrow transplantation. Blood. 1994 Nov 1; 84(9):3212-20.
  View in: PubMed
• Reece DE, Phillips GL. Intensive therapy and autotransplantation in Hodgkin's disease. Stem Cells. 1994 Sep; 12(5):477-93.
  View in: PubMed
• Klingemann HG, Eaves CJ, Barnett MJ, Eaves AC, Hogge DE, Nantel SH, Reece E, Shepherd JD, Sutherland HJ, Phillips GL. Transplantation of patients with high risk acute myeloid leukemia in first remission with autologous marrow cultured in interleukin-2 followed by interleukin-2 administration. Bone Marrow Transplant. 1994 Sep; 14(3):389-96.
  View in: PubMed
• Barnett MJ, Eaves CJ, Phillips GL, Gascoyne RD, Hogge DE, Horsman DE, Humphries RK, Klingemann HG, Lansdorp PM, Nantel SH, et al. Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study. Blood. 1994 Aug 1; 84(3):724-32.
  View in: PubMed
• Sutherland HJ, Eaves CJ, Lansdorp PM, Phillips GL, Hogge DE. Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants. Blood. 1994 Jun 15; 83(12):3808-14.
  View in: PubMed
• Phillips GL, Bundy BN, Okagaki T, Kucera PR, Stehman FB. Malignant melanoma of the vulva treated by radical hemivulvectomy. A prospective study of the Gynecologic Oncology Group. Cancer. 1994 May 15; 73(10):2626-32.
  View in: PubMed
• Reece DE, Connors JM, Spinelli JJ, Barnett MJ, Fairey RN, Klingemann HG, Nantel SH, O'Reilly S, Shepherd JD, Sutherland HJ, et al. Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy. Blood. 1994 Mar 1; 83(5):1193-9.
  View in: PubMed
• Klingemann HG, Gong HJ, Maki G, Horsman DE, Dalal BI, Phillips GL. Establishment and characterization of a human leukemic cell line (SR-91) with features suggestive of early hematopoietic progenitor cell origin. Leuk Lymphoma. 1994 Feb; 12(5-6):463-70.
  View in: PubMed
• Klingemann HG, Wilkie-Boyd K, Rubin A, Onetto N, Nantel SH, Barnett MJ, Reece DE, Shepherd JD, Phillips GL. Granulocyte-macrophage colony-stimulating factor after autologous marrow transplantation for Hodgkin's disease. Biotechnol Ther. 1994; 5(1-2):1-13.
  View in: PubMed
• Klingemann HG, Shepherd JD, Reece DE, Barnett MJ, Nantel SH, Sutherland HJ, Spinelli JJ, Phillips GL. Regimen-related acute toxicities: pathophysiology, risk factors, clinical evaluation and preventive strategies. Bone Marrow Transplant. 1994; 14 Suppl 4:S14-8.
  View in: PubMed
• Shepherd JD, Barnett MJ, Connors JM, Spinelli JJ, Sutherland HJ, Kingemann HG, Nantel SH, Reece DE, Currie CJ, Phillips GL. Allogeneic bone marrow transplantation for poor-prognosis non-Hodgkin's lymphoma. Bone Marrow Transplant. 1993 Dec; 12(6):591-6.
  View in: PubMed
• Barnett MJ, Eaves CJ, Phillips GL, Hogge DE, Klingemann HG, Lansdorp PM, Nantel SH, Reece DE, Shepherd JD, Sutherland HJ, et al. Autografting in chronic myeloid leukemia with cultured marrow: update of the Vancouver Study. Stem Cells. 1993 Oct; 11 Suppl 3:64-6.
  View in: PubMed
• Hogge DE, Sutherland HJ, Lansdorp PM, Phillips GL, Eaves CJ. The elusive peripheral blood hemopoietic stem cell. Semin Hematol. 1993 Oct; 30(4 Suppl 4):82-9; discussion 90-1.
  View in: PubMed
• Bredeson CN, Barnett MJ, Horsman DE, Dalal BI, Ragaz J, Phillips GL. Therapy-related acute myelogenous leukemia associated with 11q23 chromosomal abnormalities and topoisomerase II inhibitors: report of four additional cases and brief commentary. Leuk Lymphoma. 1993 Sep; 11(1-2):141-5.
  View in: PubMed
• Shepherd JD, Phillips GL. High-dose therapy for lymphoma. Curr Opin Oncol. 1993 Sep; 5(5):797-804.
  View in: PubMed
• Barnett MJ, Coppin CM, Murray N, Nevill TJ, Reece DE, Klingemann HG, Shepherd JD, Nantel SH, Sutherland HJ, Phillips GL. High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours. Br J Cancer. 1993 Sep; 68(3):594-8.
  View in: PubMed
• Karsan A, Gascoyne RD, Coupland RW, Shepherd JD, Phillips GL, Horsman DE. Combination of t(14;18) and a Burkitt's type translocation in B-cell malignancies. Leuk Lymphoma. 1993 Aug; 10(6):433-41.
  View in: PubMed
• Phillips GL, Longo DL. Indications for high-dose therapy with hematopoietic support in patients with Hodgkin's disease. Leukemia. 1993 Jul; 7(7):1087-90.
  View in: PubMed
• Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, Gajewski J, Hansen JA, Henslee-Downey J, McCullough J, et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med. 1993 Mar 4; 328(9):593-602.
  View in: PubMed
• Shepherd JD, Reece DE, Barnett MJ, Klingemann HG, Nantel SH, Sutherland HJ, Phillips GL. Induction therapy for acute myelogenous leukemia in patients over 60 years with intermediate-dose cytosine arabinoside, mitoxantrone and etoposide. Leuk Lymphoma. 1993 Feb; 9(3):211-5.
  View in: PubMed
• Szer J, Grigg AP, Phillips GL, Sheridan WP. Donor leucocyte infusions after chemotherapy for patients relapsing with acute leukaemia following allogeneic BMT. Bone Marrow Transplant. 1993 Feb; 11(2):109-11.
  View in: PubMed
• Reece DE, Barnett MJ, Connors JM, Klingemann HG, O'Reilly SE, Shepherd JD, Sutherland HJ, Phillips GL. Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamide. Bone Marrow Transplant. 1993 Feb; 11(2):139-46.
  View in: PubMed
• Grigg AP, Gascoyne RD, Phillips GL, Horsman DE. Clinical, haematological and cytogenetic features in 24 patients with structural rearrangements of the Q arm of chromosome 3. Br J Haematol. 1993 Jan; 83(1):158-65.
  View in: PubMed
• Reece DE, Elmongy MB, Barnett MJ, Klingemann HG, Shepherd JD, Phillips GL. Chemotherapy with high-dose cytosine arabinoside and mitoxantrone for poor-prognosis myeloid leukemias. Cancer Invest. 1993; 11(5):509-16.
  View in: PubMed
• Chow AW, Jewesson PJ, Kureishi A, Phillips GL. Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients. Eur J Haematol Suppl. 1993; 54:18-24.
  View in: PubMed
• Embree L, Burns RB, Heggie JR, Phillips GL, Reece DE, Spinelli JJ, Hartley DO, Hudon NJ, Goldie JH. Gas-chromatographic analysis of busulfan for therapeutic drug monitoring. Cancer Chemother Pharmacol. 1993; 32(2):137-42.
  View in: PubMed
• Eaves AC, Eaves CJ, Phillips GL, Barnett MJ. Culture purging in leukemia: past, present, and future. Leuk Lymphoma. 1993; 11 Suppl 1:259-63.
  View in: PubMed
• Barnett MJ, Eaves CJ, Phillips GL, Hogge DE, Klingemann HG, Lansdorp PM, Nantel SH, Reece DE, Shepherd JD, Sutherland HJ, et al. Autografting in chronic myeloid leukemia with cultured marrow. Leukemia. 1992 Nov; 6 Suppl 4:118-9.
  View in: PubMed
• Nevill TJ, Shepherd JD, Reece DE, Barnett MJ, Nantel SH, Klingemann HG, Phillips GL. Treatment of myelodysplastic syndrome with busulfan-cyclophosphamide conditioning followed by allogeneic BMT. Bone Marrow Transplant. 1992 Nov; 10(5):445-50.
  View in: PubMed
• Cuthbert RJ, Phillips GL, Barnett MJ, Nantel SH, Reece DE, Shepherd JD, Klingemann HG. Anti-interleukin-2 receptor monoclonal antibody (BT 563) in the treatment of severe acute GVHD refractory to systemic corticosteroid therapy. Bone Marrow Transplant. 1992 Nov; 10(5):451-5.
  View in: PubMed
• Wolff SN, Brown RA, Fay JW, Herzig GP, Herzig RH, Phillips GL. High-dose cytosine arabinoside for the treatment of acute myeloid leukemia. Studies of the North American Marrow Transplant Group. Leukemia. 1992 Nov; 6 Suppl 4:71-4.
  View in: PubMed
• Biggs JC, Horowitz MM, Gale RP, Ash RC, Atkinson K, Helbig W, Jacobsen N, Phillips GL, Rimm AA, Ringdén O, et al. Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy. Blood. 1992 Aug 15; 80(4):1090-3.
  View in: PubMed
• Grigg AP, Berean K, Shore T, Phillips GL. Pancytopenia due to hypersplenism after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1992 Aug; 10(2):177-9.
  View in: PubMed
• Nevill TJ, Tirgan MH, Deeg HJ, Klingemann HG, Reece DE, Shepherd JD, Barnett MJ, Phillips GL. Influence of post-methotrexate folinic acid rescue on regimen-related toxicity and graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1992 May; 9(5):349-54.
  View in: PubMed
• Herbetko J, Grigg AP, Buckley AR, Phillips GL. Venoocclusive liver disease after bone marrow transplantation: findings at duplex sonography. AJR Am J Roentgenol. 1992 May; 158(5):1001-5.
  View in: PubMed
• Thomas TE, Abraham SJ, Phillips GL, Lansdorp PM. A simple procedure for large-scale density separation of bone marrow cells for transplantation. Transplantation. 1992 May; 53(5):1163-5.
  View in: PubMed
• Kohn FR, Phillips GL, Klingemann HG. Regulation of tumor necrosis factor-alpha production and gene expression in monocytes. Bone Marrow Transplant. 1992 May; 9(5):369-76.
  View in: PubMed
• Nevill TJ, Barnett MJ, Robinson KS, Greer W, Phillips GL. Return to durable donor haematopoiesis after blast phase relapse of chronic myeloid leukaemia following marrow transplantation. Br J Haematol. 1992 Feb; 80(2):256-8.
  View in: PubMed
• Eaves CJ, Sutherland HJ, Udomsakdi C, Lansdorp PM, Szilvassy SJ, Fraser CC, Humphries RK, Barnett MJ, Phillips GL, Eaves AC. The human hematopoietic stem cell in vitro and in vivo. Blood Cells. 1992; 18(2):301-7.
  View in: PubMed
• Phillips GL, Reece DE, Connors JM. Bone marrow transplantation in Hodgkin's disease. Bone Marrow Transplant. 1992; 10 Suppl 1:64-6.
  View in: PubMed
• Klingemann HG, Grigg AP, Wilkie-Boyd K, Barnett MJ, Eaves AC, Reece DE, Shepherd JD, Phillips GL. Treatment with recombinant interferon (alpha-2b) early after bone marrow transplantation in patients at high risk for relapse [corrected]. Blood. 1991 Dec 15; 78(12):3306-11.
  View in: PubMed
• Phillips GL, Barnett MJ, Brain MC, Chan KW, Huebsch LB, Klingemann HG, Meharchand J, Reece DE, Rybka WB, Shepherd JD, et al. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group. Bone Marrow Transplant. 1991 Dec; 8(6):477-87.
  View in: PubMed
• Shepherd JD, Pringle LE, Barnett MJ, Klingemann HG, Reece DE, Phillips GL. Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation. J Clin Oncol. 1991 Nov; 9(11):2016-20.
  View in: PubMed
• Reece DE, Frei-Lahr DA, Shepherd JD, Dorovini-Zis K, Gascoyne RD, Graeb DA, Spinelli JJ, Barnett MJ, Klingemann HG, Herzig GP, et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant. 1991 Nov; 8(5):393-401.
  View in: PubMed
• Kureishi A, Jewesson PJ, Rubinger M, Cole CD, Reece DE, Phillips GL, Smith JA, Chow AW. Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity. Antimicrob Agents Chemother. 1991 Nov; 35(11):2246-52.
  View in: PubMed
• Reece DE, Barnett MJ, Connors JM, Fairey RN, Fay JW, Greer JP, Herzig GP, Herzig RH, Klingemann HG, LeMaistre CF, et al. Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease. J Clin Oncol. 1991 Oct; 9(10):1871-9.
  View in: PubMed
• Phillips GL, Shepherd JD, Barnett MJ, Lansdorp PM, Klingemann HG, Spinelli JJ, Nevill TJ, Chan KW, Reece DE. Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancy. J Clin Oncol. 1991 Oct; 9(10):1880-8.
  View in: PubMed
• Klingemann HG, Phillips GL. Immunotherapy after bone marrow transplantation. Bone Marrow Transplant. 1991 Aug; 8(2):73-81.
  View in: PubMed
• Nevill TJ, Barnett MJ, Klingemann HG, Reece DE, Shepherd JD, Phillips GL. Regimen-related toxicity of a busulfan-cyclophosphamide conditioning regimen in 70 patients undergoing allogeneic bone marrow transplantation. J Clin Oncol. 1991 Jul; 9(7):1224-32.
  View in: PubMed
• Turhan AG, Eaves CJ, Humphries RK, Phillips GL, Eaves AC. Reversing clonality in leukemia. Semin Hematol. 1991 Jul; 28(3 Suppl 4):5-8.
  View in: PubMed
• Lohri A, Barnett M, Fairey RN, O'Reilly SE, Phillips GL, Reece D, Voss N, Connors JM. Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988. Blood. 1991 May 15; 77(10):2292-8.
  View in: PubMed
• Phillips GL, Reece DE, Shepherd JD, Barnett MJ, Brown RA, Frei-Lahr DA, Klingemann HG, Bolwell BJ, Spinelli JJ, Herzig RH, et al. High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adults. Blood. 1991 Apr 1; 77(7):1429-35.
  View in: PubMed
• Klingemann HG, Kohn FR, Phillips GL. Proliferation of peripheral lymphocytes to interleukin-2 and interleukin-4 after marrow transplantation. Eur Cytokine Netw. 1991 Mar-Apr; 2(2):131-6.
  View in: PubMed
• Phillips GL. The use of unrelated donors (UD) for allogeneic bone marrow transplantation (BMT): a pilot study of the Canadian BMT Group. Bone Marrow Transplant. 1991; 7 Suppl 1:52-3.
  View in: PubMed
• Barnett MJ, Sutherland HJ, Eaves AC, Hogge DE, Humphries RK, Klingemann HG, Lansdorp PM, Phillips GL, Reece DE, Shepherd JD, et al. Human hematopoietic stem cells in long-term culture: quantitation and manipulation. Bone Marrow Transplant. 1991; 7 Suppl 1:70.
  View in: PubMed
• Turhan AG, Humphries RK, Eaves CJ, Barnett MJ, Phillips GL, Kalousek DK, Klingemann HG, Lansdorp PL, Reece DE, Shepherd JD, et al. Detection of breakpoint cluster region- negative and nonclonal hematopoiesis in vitro and in vivo after transplantation of cells selected in cultures of chronic myeloid leukemia marrow. Blood. 1990 Dec 1; 76(11):2404-10.
  View in: PubMed
• Klingemann HG, Barnett MJ, Reece DE, Shepherd JD, Phillips GL. Use of an immunoglobulin preparation enriched for IgM (Pentaglobin) for the treatment of acute graft-versus-host disease. Bone Marrow Transplant. 1990 Sep; 6(3):199-202.
  View in: PubMed
• Phillips GL. Current management of vulvar melanoma. Oncology (Williston Park). 1990 Sep; 4(9):61-4; discussion 66, 68.
  View in: PubMed
• Barnett MJ, Eaves AC, Phillips GL. An overview of bone marrow transplantation for chronic myeloid leukemia. CMAJ. 1990 Aug 1; 143(3):187-93.
  View in: PubMed
• Phillips GL, Reece DE, Lerner KG, Connors JM. Intensive chemotherapy and autologous peripheral blood stem cell transplantation in a patient with persistent marrow involvement with Hodgkin's disease. Bone Marrow Transplant. 1990 Jul; 6(1):45-7.
  View in: PubMed
• Epstein JB, Sherlock C, Page JL, Spinelli J, Phillips G. Clinical study of herpes simplex virus infection in leukemia. Oral Surg Oral Med Oral Pathol. 1990 Jul; 70(1):38-43.
  View in: PubMed
• Klingemann HG, Phillips GL. Double negative (CD4/CD8) T cell receptor alpha/beta positive lymphocytes in patients with graft-versus-host disease. Bone Marrow Transplant. 1990 May; 5(5):364.
  View in: PubMed
• Keown PA, Glenn J, Denegri J, Maciejewska U, Seccombe D, Stawecki M, Freeman D, Stiller C, Shackleton C, Cameron E, et al. Therapeutic monitoring of cyclosporine: impact of a change in standards on 125I-monoclonal RIA performance in comparison with liquid chromatography. Clin Chem. 1990 May; 36(5):804-7.
  View in: PubMed
• Byers VS, Henslee PJ, Kernan NA, Blazar BR, Gingrich R, Phillips GL, LeMaistre CF, Gilliland G, Antin JH, Martin P, et al. Use of an anti-pan T-lymphocyte ricin a chain immunotoxin in steroid-resistant acute graft-versus-host disease. Blood. 1990 Apr 1; 75(7):1426-32.
  View in: PubMed
• Klingemann HG, Eaves AC, Barnett MJ, Reece DE, Shepherd JD, Belch AR, Brandwein JM, Langleben A, Koch PA, Phillips GL. Recombinant GM-CSF in patients with poor graft function after bone marrow transplantation. Clin Invest Med. 1990 Apr; 13(2):77-81.
  View in: PubMed
• Klingemann HG, Barnett MJ, Phillips GL. Use of an immunoglobulin preparation enriched for IgA to treat recurrent sinopulmonary infections in a patient with chronic GVHD. Bone Marrow Transplant. 1990 Mar; 5(3):205.
  View in: PubMed
• Phillips GL, Fay JW, Herzig RH, Lazarus HM, Wolff SN, Lin HS, Shina DC, Glasgow GP, Griffith RC, Lamb CW, et al. The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantation. Blood. 1990 Feb 15; 75(4):831-8.
  View in: PubMed
• Shore T, Barnett MJ, Phillips GL. Sudden neurologic death after intrathecal methotrexate. Med Pediatr Oncol. 1990; 18(2):159-61.
  View in: PubMed
• Phillips GL. Autologous bone marrow transplantation for hematologic cancer. Prog Clin Biol Res. 1990; 354B:171-84.
  View in: PubMed
• Grigg AP, Shepherd JD, Phillips GL. Busulphan and phenytoin. Ann Intern Med. 1989 Dec 15; 111(12):1049-50.
  View in: PubMed
• Wolff SN, Herzig RH, Fay JW, Phillips GL, Lazarus HM, Flexner JM, Stein RS, Greer JP, Cooper B, Herzig GP. High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results. J Clin Oncol. 1989 Sep; 7(9):1260-7.
  View in: PubMed
• Phillips GL, Reece DE, Barnett MJ, Connors JM, Fay JW, Herzig GP, Herzig RH, Klingemann HG, Shepherd JD, Wolff SN. Allogeneic marrow transplantation for refractory Hodgkin's disease. J Clin Oncol. 1989 Aug; 7(8):1039-45.
  View in: PubMed
• Barnett MJ, Eaves CJ, Phillips GL, Kalousek DK, Klingemann HG, Lansdorp PM, Reece DE, Shepherd JD, Shaw GJ, Eaves AC. Successful autografting in chronic myeloid leukaemia after maintenance of marrow in culture. Bone Marrow Transplant. 1989 Jul; 4(4):345-51.
  View in: PubMed
• Turhan AG, Humphries RK, Phillips GL, Eaves AC, Eaves CJ. Clonal hematopoiesis demonstrated by X-linked DNA polymorphisms after allogeneic bone marrow transplantation. N Engl J Med. 1989 Jun 22; 320(25):1655-61.
  View in: PubMed
• Phillips GL, Wolff SN, Herzig RH, Lazarus HM, Fay JW, Lin HS, Shina DC, Glasgow GP, Griffith RC, Lamb CW, et al. Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation. Blood. 1989 Jun; 73(8):2086-92.
  View in: PubMed
• Shepherd JD, Shore TB, Reece DE, Barnett MJ, Klingemann HG, Buskard NA, Phillips GL. Cyclosporine and methylprednisolone for prophylaxis of acute graft-versus-host disease. Bone Marrow Transplant. 1988 Nov; 3(6):553-8.
  View in: PubMed
• McGregor GI, Shepherd JD, Phillips GL. Acute graft-versus-host disease of the intestine. A surgical perspective. Am J Surg. 1988 May; 155(5):680-2.
  View in: PubMed
• Klingemann HG, Phillips GL. CMV immunoglobulin for prevention of pneumonitis after BMT. Bone Marrow Transplant. 1988 May; 3(3):235-6.
  View in: PubMed
• Herzig RH, Hines JD, Herzig GP, Wolff SN, Cassileth PA, Lazarus HM, Adelstein DJ, Brown RA, Coccia PF, Strandjord S, et al. Cerebellar toxicity with high-dose cytosine arabinoside. J Clin Oncol. 1987 Jun; 5(6):927-32.
  View in: PubMed
• Wolff SN, Herzig RH, Phillips GL, Lazarus HM, Greer JP, Stein RS, Ray WA, Herzig GP. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update. Semin Oncol. 1987 Jun; 14(2 Suppl 1):12-7.
  View in: PubMed
• Chan KW, Fryer CJ, Denegri JF, Buskard NA, Phillips GL. Allogeneic bone marrow transplantation using partially-matched related donors. Bone Marrow Transplant. 1987 Jun; 2(1):27-32.
  View in: PubMed
• Herzig RH, Herzig GP, Wolff SN, Hines JD, Fay JW, Phillips GL. Central nervous system effects of high-dose cytosine arabinoside. Semin Oncol. 1987 Jun; 14(2 Suppl 1):21-4.
  View in: PubMed
• Wolff SN, Phillips GL, Herzig GP. High-dose carmustine with autologous bone marrow transplantation for the adjuvant treatment of high-grade gliomas of the central nervous system. Cancer Treat Rep. 1987 Feb; 71(2):183-5.
  View in: PubMed
• Phillips GL, Wolff SN, Fay JW, Herzig RH, Lazarus HM, Schold C, Herzig GP. Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma. J Clin Oncol. 1986 May; 4(5):639-45.
  View in: PubMed
• Phillips GL, Herzig RH, Lazarus HM, Fay JW, Griffith R, Herzig GP. High-dose chemotherapy, fractionated total-body irradiation, and allogeneic marrow transplantation for malignant lymphoma. J Clin Oncol. 1986 Apr; 4(4):480-8.
  View in: PubMed
• Phillips GL, Reece DE. Clinical studies of autologous bone marrow transplantation in Hodgkin's disease. Clin Haematol. 1986 Feb; 15(1):151-66.
  View in: PubMed
• Reece DE, Buskard NA, Hill RS, Fryer CJ, Naiman SC, Phillips GL. Allogeneic bone marrow transplantation for Philadelphia-chromosome positive acute lymphoblastic leukemia. Leuk Res. 1986; 10(4):457-9.
  View in: PubMed
• Phillips GL, Frye LP. Adenoid cystic carcinoma of the cervix: a case report with implications for chemotherapeutic treatment. Gynecol Oncol. 1985 Oct; 22(2):260-2.
  View in: PubMed
• Herzig RH, Lazarus HM, Wolff SN, Phillips GL, Herzig GP. High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia. J Clin Oncol. 1985 Jul; 3(7):992-7.
  View in: PubMed
• Herzig RH, Phillips GL, Lazarus HM, Wolff SN, Herzig GP. High-dose cytarabine for the treatment of blastic phase chronic myelogenous leukemia. Cancer Treat Rep. 1985 Jul-Aug; 69(7-8):881-3.
  View in: PubMed
• Wolff SN, Marion J, Stein RS, Flexner JM, Lazarus HM, Spitzer TR, Phillips GL, Herzig RH, Herzig GP. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: a pilot study. Blood. 1985 Jun; 65(6):1407-11.
  View in: PubMed
• Lazarus HM, Herzig RH, Wolff SN, Phillips GL, Spitzer TR, Fay JW, Herzig GP. Treatment of metastatic malignant melanoma with intensive melphalan and autologous bone marrow transplantation. Cancer Treat Rep. 1985 May; 69(5):473-7.
  View in: PubMed
• Phillips GL, Herzig RH, Lazarus HM, Fay JW, Wolff SN, Mill WB, Lin H, Thomas PR, Glasgow GP, Shina DC, et al. Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrow. N Engl J Med. 1984 Jun 14; 310(24):1557-61.
  View in: PubMed
• Phillips GL, Herzig GP. Intensive chemotherapy, total body irradiation, and autologous marrow transplantation for chronic granulocytic leukemia-blast phase: report of four additional cases. J Clin Oncol. 1984 May; 2(5):379-84.
  View in: PubMed
• Phillips GL, Fay JW, Herzig GP, Herzig RH, Weiner RS, Wolff SN, Lazarus HM, Karanes C, Ross WE, Kramer BS. Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study. Cancer. 1983 Nov 15; 52(10):1792-802.
  View in: PubMed
• Herzig RH, Wolff SN, Lazarus HM, Phillips GL, Karanes C, Herzig GP. High-dose cytosine arabinoside therapy for refractory leukemia. Blood. 1983 Aug; 62(2):361-9.
  View in: PubMed
• Wolff SN, Katzenstein AL, Phillips GL, Herzig GP. Aspiration does not influence interpretation of bone marrow biopsy cellularity. Am J Clin Pathol. 1983 Jul; 80(1):60-2.
  View in: PubMed
• Lazarus HM, Herzig RH, Graham-Pole J, Wolff SN, Phillips GL, Strandjord S, Hurd D, Forman W, Gordon EM, Coccia P, et al. Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer. J Clin Oncol. 1983 Jun; 1(6):359-67.
  View in: PubMed
• Strayer DS, Phillips GB, Herzig G, Bari W, Santa Cruz DJ. Acute myelomonocytic leukemia presenting as a primary cutaneous lymphoma of true histiocytes. J Am Acad Dermatol. 1982 Aug; 7(2):229-35.
  View in: PubMed
• Murphy S, Kahn RA, Holme S, Phillips GL, Sherwood W, Davisson W, Buchholz DH. Improved storage of platelets for transfusion in a new container. Blood. 1982 Jul; 60(1):194-200.
  View in: PubMed
• Lazarus HM, Gottfried MR, Herzig RH, Phillips GL, Weiner RS, Sarna GP, Fay J, Wolff SN, Sudilovsky O, Gale RP, Herzig GP. Veno-occlusive disease of the liver after high-dose mitomycin C therapy and autologous bone marrow transplantation. Cancer. 1982 May 1; 49(9):1789-95.
  View in: PubMed
• Herzig RH, Lazarus HM, Graham-Pole J, Gross S, Coccia P, Gordon EM, Strandjord S, Phillips GL, Herzig GP. Bone marrow transplantation with high-dose cytosine arabinoside. Med Pediatr Oncol. 1982; 10 Suppl 1:235-8.
  View in: PubMed
• Lazarus HM, Herzig RH, Herzig GP, Phillips GL, Roessmann U, Fishman DJ. Central nervous system toxicity of high-dose systemic cytosine arabinoside. Cancer. 1981 Dec 15; 48(12):2577-82.
  View in: PubMed
• Strayer DS, Phillips GB, Barker KH, Winokur T, DeSchryver-Kecskemeti K. Gastric cytomegalovirus infection in bone marrow transplant patients: an indication of generalized disease. Cancer. 1981 Sep 15; 48(6):1478-83.
  View in: PubMed
• Kahn RA, Staggs SD, Phillips GL. Recovery, life span, and function of stored plateletpheresis units. Vox Sang. 1981 Apr; 40(4):253-9.
  View in: PubMed
• Glasgow GP, Mill WB, Phillips GL, Herzig GP. Comparative 60Co total body irradiation (220 cm SAD) and 25 MV total body irradiation (370 cm SAD) dosimetry. Int J Radiat Oncol Biol Phys. 1980 Sep; 6(9):1243-50.
  View in: PubMed
• Presant CA, Berger NA, Klahr C, Phillips GL. Remission maintenance for acute nonlymphocytic leukemia: cytosine arabinoside plus 6-thioguanine versus a sequence of drug regimens. Cancer. 1980 Jul 1; 46(1):22-8.
  View in: PubMed
• Phillips GL, Fay JW, Herzig GP, NaPombejara C, Wolff SN. Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) autologous bone marrow transplantation therapy of refractory cancer: a preliminary report. Exp Hematol. 1979; 7 Suppl 5:372-83.
  View in: PubMed
• Pearson RE, Thudium VF, Phillips GL. II. Drug therapy analysis--a model. Am J Hosp Pharm. 1971 Jul; 28(7):513-5.
  View in: PubMed